The aim of this study was to investigate the associations between MI, macrophage traits of breast cancer cells (as defined by CD163-expression), clinicopathological data, and disease recurrence in relation to RT in a well-defined patient cohort treated with breast-conserving surgery for non-metastatic breast cancer. Here, CD163 is linked to breast cancer.